Fred guengerich

array of test tubes with pipette dropping fluid into one
September 20, 2019

Guengerich, Sanders-Bush named ASPET fellows

Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

By Bill Snyder
June 12, 2019

Steroid binding to metabolic enzyme

Understanding how a steroid-metabolizing enzyme binds to its substrates may aid in designing drugs to treat sexual dysfunction as well as prostate cancer.

By Bill Snyder
August 25, 2015

How the cell makes morphine

Vanderbilt investigators have discovered how mammals, including humans, produce the painkiller morphine.

By Sanjay Mishra
July 9, 2015

Guengerich named interim editor of noted journal JBC

Vanderbilt University’s F. Peter (Fred) Guengerich, Ph.D., has been named interim editor-in-chief of the Journal of Biological Chemistry (JBC).

By Bill Snyder
DNA sequence
October 31, 2013

VU ‘crosslinks’ study sheds light on chemical toxicity

Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities.

By Bill Snyder
May 2, 2013

Awards given at Postdoctoral Research Symposium

By Bill Snyder
January 24, 2013

Toxicology society honors Guengerich

F. Peter (Fred) Guengerich, Ph.D., Stanford Moore Professor of Biochemistry, is the 2013 recipient of the Society of Toxicology Merit Award in recognition of distinguished achievements to toxicology throughout his career.
By Bill Snyder